L1CAM further stratifies endometrial carcinoma patients with no specific molecular risk profile

BACKGROUND: The newly developed Proactive Molecular Risk Classifier for Endometrial Cancer (ProMisE) has consistently been shown to be prognostically significant in endometrial carcinomas (EC). Recently, we and others have demonstrated L1 cell-adhesion molecule (L1CAM) to be a significant indicator...

Celý popis

Uloženo v:
Podrobná bibliografie
Vydáno v:Br J Cancer
Hlavní autoři: Kommoss, Felix KF, Karnezis, Anthony N., Kommoss, Friedrich, Talhouk, Aline, Taran, Florin-Andrei, Staebler, Annette, Gilks, C. Blake, Huntsman, David G., Krämer, Bernhard, Brucker, Sara Y., McAlpine, Jessica N., Kommoss, Stefan
Médium: Artigo
Jazyk:Inglês
Vydáno: Nature Publishing Group UK 2018
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC6134076/
https://ncbi.nlm.nih.gov/pubmed/30050154
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1038/s41416-018-0187-6
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky